The effect of additives on behavior of the high temperature LaxY1-xBa2Cu3O7-δ superconductor
Experimental and Theoretical NANOTECHNOLOGY · 2017
DOI: 10.56053/1.1.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental and Theoretical NANOTECHNOLOGY, 2017. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
A series of ceramic superconductor compounds with the composition LaxY1-x Ba2Cu3O7-δ are prepared by solid state reaction from the principle routs like La2O3, BaCO3 and CuO with high purity 99.99%. Different measurement is made to show the improvement in high phase superconductor such as resistivity measurement and the X-ray diffraction (XRD). When (x=0.20 and 0.80; x=0.40 and 0.60) an orthorhombic phase is appeared with lattice constants (a= 3.844 Å, b=3.912 Å, c=11.839 Å) and (a= 3.871 Å, b=3.881 Å, c=11.748Å), respectively. This emphasizes the formation of a high temperature superconducting phase. At x=0.5 a phase is changed to a tetragonal where the superconductivity is lost. From the resistivity measurement, the highest (Tc) value is found equals to (97K) for (x=0.20 and x=0.80) comparable with the YBCO-compound which does not normally exhibited Tc-value greater than (95K). The increase in Tc-value may be attributed to the amount of (La) and / or the oxygen content in the mixture which both influence the properties of the compound and are essential for the superconductivity phase.
Zitieren
APA
(2017). The effect of additives on behavior of the high temperature LaxY1-xBa2Cu3O7-δ superconductor. Experimental and Theoretical NANOTECHNOLOGY. https://doi.org/10.56053/1.1.1
Vancouver
The effect of additives on behavior of the high temperature LaxY1-xBa2Cu3O7-δ superconductor. Experimental and Theoretical NANOTECHNOLOGY. 2017. doi:10.56053/1.1.1
BibTeX
@article{euvimed2017,
title = {The effect of additives on behavior of the high temperature LaxY1-xBa2Cu3O7-δ superconductor},
journal = {Experimental and Theoretical NANOTECHNOLOGY},
year = {2017},
doi = {10.56053/1.1.1}
}
EUVIMED